← Back to Search

Neuromuscular Training for ACL Injury

Waitlist Available
Led By Gregory D Myer, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-training testing), week 6 (post-training testing)
Awards & highlights

Study Summary

This trial will study how well a new type of training that uses brain feedback helps people's muscles get stronger.

Eligible Conditions
  • Anterior Cruciate Ligament (ACL) Injury
  • Anterior Cruciate Ligament Injury


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-training testing), week 6 (post-training testing)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-training testing), week 6 (post-training testing) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diffusion Tensor Imaging
Secondary outcome measures
Change in TBSS measured change in fMRI regions of interest

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: aNMT BiofeedbackExperimental Treatment1 Intervention
Participants randomized to receive a neuromuscular training intervention that incorporates biofeedback training.
Group II: Sham BiofeedbackPlacebo Group1 Intervention
Participants randomized to receive a neuromuscular training intervention with sham feedback training.

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,655 Previous Clinical Trials
2,572,898 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiLead Sponsor
816 Previous Clinical Trials
6,575,086 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
486 Previous Clinical Trials
1,086,720 Total Patients Enrolled
5 Trials studying Anterior Cruciate Ligament Injury
1,424 Patients Enrolled for Anterior Cruciate Ligament Injury

Media Library

aNMT Biofeedback Clinical Trial Eligibility Overview. Trial Name: NCT04069520 — N/A
Anterior Cruciate Ligament Injury Research Study Groups: aNMT Biofeedback, Sham Biofeedback
Anterior Cruciate Ligament Injury Clinical Trial 2023: aNMT Biofeedback Highlights & Side Effects. Trial Name: NCT04069520 — N/A
aNMT Biofeedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT04069520 — N/A
~15 spots leftby Jun 2025